Nilanjan Sinha
About Nilanjan Sinha
Data last updated:
Nilanjan Sinha is a Director at Iqvia Rds (India) Private Limited (since 2017) and Director at Iqvia Analytics Services Private Limited (since 2018). The companies operate in Information Technology, Travel and Hospitality and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹4,792 Cr; the largest is Iqvia Rds (India) Private Limited at ₹3,342 Cr (FY 2025). Earlier, Nilanjan Sinha was a Director at Excel Life Sciences Private Limited (2019–2025) and Director at Aecio It Solutions India Private Limited (2018–2023) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Iqvia Rds (India) Private Limited U74909KA2002PTC107115 | Director | 05 Jan 2017 | 2002 | ₹3,342 Cr (FY 2025) | Active |
| Iqvia Analytics Services Private Limited U74140KA2003PTC032950 | Director | 14 Sep 2018 | 2003 | ₹1,450 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Excel Life Sciences Private Limited U24231KA2005PTC174337 | Director | 15 May 2019 | 2005 | ₹7.85 Cr (FY 2023) | Active |
 Aecio It Solutions India Private Limited U74900KA2016FTC129274 | Director | 25 Sep 2018 | 2016 | ₹4.33 Cr (FY 2024) | Under Liquidation |
| 159 Technology Solutions Private Limited U74900KA2015PTC126500 | Director | 27 Sep 2018 | 2015 | ₹39.04 Cr (FY 2025) | Active |
 Ims Health Technology Solutions India Private Limited U72200KA2004FTC033439 | Director | 02 Jul 2018 | 2004 | ₹56.91 Cr (FY 2018) | Amalgamated |
 Cenduit (India) Services Private Limited U72200KA2007PTC042174 | Director | 08 Mar 2017 | 2007 | ₹74.87 Cr (FY 2021) | Amalgamated |
 Quintiles Phase One Clinical Trials India Private Limited U73100TG2009FTC064239 | Director | 14 Nov 2016 | 2009 | ₹4.16 Cr (FY 2020) | Dissolved (Liquidated) |
| Clintec Cro Services (India) Private Limited U73100KA2019PTC125252 | Director | 14 Jun 2019 | 2019 | ₹3.78 Cr (FY 2022) | Dissolved Under Section 59(8) |
| Q Squared Solutions (India) Private Limited U74999MH2015FTC267956 | Director | 27 Mar 2017 | 2015 | Dissolved Under Section 59(8) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nilanjan Sinha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gaurav Shankar Lal | 09060003 | Iqvia Rds (India) Private Limited , Iqvia Analytics Services Private Limited | Director |
| Madhvi Shankar | 09263870 | Iqvia Rds (India) Private Limited | Director |
| Vineet Kumar Bajpai | 08099634 | Iqvia Rds (India) Private Limited | Director |
| Arita Bhattacharya | Iqvia Analytics Services Private Limited | Company Secretary | |
| David Jacob Cossitt Levy | 08191095 | Iqvia Analytics Services Private Limited | Director |
| Prashant Parab | 07708099 | Iqvia Analytics Services Private Limited | Director |
| Vardham Krishna Murthy Kumar Babu | 09082974 | Iqvia Analytics Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilanjan Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilanjan Sinha
Nilanjan Sinha currently holds 2 directorships: Iqvia Rds (India) Private Limited (Director, since 05 Jan 2017, revenue ₹3,342 Cr (FY 2025)); Iqvia Analytics Services Private Limited (Director, since 14 Sep 2018, revenue ₹1,450 Cr (FY 2025)).
Nilanjan Sinha was first appointed on 14 Nov 2016 as Director at Quintiles Phase One Clinical Trials India Private Limited. The most recent appointment on record is 14 Jun 2019 at Clintec Cro Services (India) Private Limited.
The 2 current companies of Nilanjan Sinha that report revenue have a combined latest revenue of ₹4,792 Cr: Iqvia Rds (India) Private Limited ₹3,342 Cr (FY 2025); Iqvia Analytics Services Private Limited ₹1,450 Cr (FY 2025).
Nilanjan Sinha held 8 earlier board appointments: Excel Life Sciences Private Limited (Director, 15 May 2019 to 01 May 2025); Aecio It Solutions India Private Limited (Director, 25 Sep 2018 to 22 Jun 2023); 159 Technology Solutions Private Limited (Director, 27 Sep 2018 to 23 May 2023); Ims Health Technology Solutions India Private Limited (Director, from 02 Jul 2018); Cenduit (India) Services Private Limited (Director, from 08 Mar 2017); and 3 more.
The current boards of Nilanjan Sinha's companies include Gaurav Shankar Lal (Iqvia Rds (India) Private Limited), Madhvi Shankar (Iqvia Rds (India) Private Limited), Vineet Kumar Bajpai (Iqvia Rds (India) Private Limited), Arita Bhattacharya (Iqvia Analytics Services Private Limited), David Jacob Cossitt Levy (Iqvia Analytics Services Private Limited), Prashant Parab (Iqvia Analytics Services Private Limited), among others.